
Wellbird Pharma Private Limited
About Wellbird Pharma Private Limited
Data last updated:
Wellbird Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2017PTC059788. Its GSTIN is 08AAZCS6088G1ZF (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Sundreems Pharmaceuticals Private Limited. It is led by directors including Gaurav Agrawal and Narayan Kumar Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 102/G – 13 Signature Residency Hathi Babu Marg Bani Park, Jaipur, Rajasthan, India – 302016.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.92 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹30,575 (net margin -0.6%) and EBITDA of ₹91,277 (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Wellbird Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered Address102/G – 13 Signature Residency Hathi Babu Marg Bani Park, Jaipur, Rajasthan, India – 302016
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Wellbird Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wellbird Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wellbird Pharma Private Limited, buy the company report.
Financials of Wellbird Pharma Private Limited
FY 2025 filings availableWellbird Pharma Private Limited reported revenue of ₹50.92 Lakh (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 32% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹91,277 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹30,575 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | -0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wellbird Pharma Private Limited, buy the company report.
Board of directors of Wellbird Pharma Private Limited
Wellbird Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Agrawal | Director | 18 Dec 2017 | 8 Years 11 Months | Current |
| Narayan Kumar Agrawal | Director | 18 Dec 2017 | 8 Years 11 Months | Current |
| Archana Agrawal | Director | 18 Dec 2017 | 8 Years 11 Months | Current |
Peer comparison
Wellbird Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| E T M Oushadhasala and Hospitals Private Limited | ₹53.12 Lakh (FY 2025) | 17.0% | Thrissur, Kerala, India | |||
| Om Medipharmaceuticals Private Limited | ₹52.35 Lakh (FY 2024) | -16.0% | Jaipur, Rajasthan, India | |||
| Wellbird Pharma Private Limitedthis company | ₹50.92 Lakh (FY 2025) | -₹30,575 | -0.6% | 32.0% | Jaipur, Rajasthan, India | |
| Narayan's Rreamedy's Private Limited | ₹49.99 Lakh (FY 2021) | -33.0% | Pune, Maharashtra, India |
To see the full peer comparison of Wellbird Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wellbird Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wellbird Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wellbird Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAZCS6088G1ZF | Rajasthan | Active | 22 Aug 2019 |
To see the full GST registrations and return filing status of Wellbird Pharma Private Limited, buy the company report.
Recent activity
Wellbird Pharma Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Archana Agrawal was appointed as Director on 18 Dec 2017.
Frequently asked questions
Wellbird Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 December 2017 (9+ years old) and is registered under CIN U24100RJ2017PTC059788.
Wellbird Pharma has 3 current directors:
- Gaurav Agrawal - Director
- Narayan Kumar Agrawal - Director
- Archana Agrawal - Director
The latest financial statements of Wellbird Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Wellbird Pharma is 08AAZCS6088G1ZF, registered in Rajasthan.
The CIN (Corporate Identification Number) of Wellbird Pharma is U24100RJ2017PTC059788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wellbird Pharma was incorporated on 18 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Wellbird Pharma by revenue are E T M Oushadhasala and Hospitals Private Limited, Om Medipharmaceuticals Private Limited, Narayan's Rreamedy's Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Archana Agrawal was appointed as Director on 18 Dec 2017. Gaurav Agrawal was appointed as Director on 18 Dec 2017. Narayan Kumar Agrawal was appointed as Director on 18 Dec 2017.
The registered office of Wellbird Pharma is at 102G – 13 Signature Residency Hathi Babu Marg Bani Park, Jaipur, Rajasthan, India – 302016.
Wellbird Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Wellbird Pharma is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.

